|
|
|
Print this article 
SOT Continues to Provide High Quality Educational Opportunities through Continuing Education Courses in Salt Lake City
Providing quality education to help advance the science of toxicology is an important goal of SOT. Every year, top scientists in the field come together to create these unique educational courses and make them available to you. This year is no exception, and SOT will offer thirteen Continuing Education Courses on Sunday, March 7, 2010, at the Salt Palace Convention Center. A single sunrise course will begin at 7:00 AM, followed by six morning courses starting at 8:15 AM and six afternoon courses at 1:15 PM. The courses will encompass a rich variety of topics, including the following:
- Genomic and proteomic data sets can be interrogated by some presently available knowledge bases to identify relevant biological pathways of toxicity. (SR01)
- Historical information as well as scientific, risk/benefit, and regulatory concerns should be considered before and during human clinical trials. (AM02)
- Translational toxicology requires an understanding of species-dependent differences in lung structure and function. (AM03)
- Special consideration is required when addressing the toxicity and/or therapeutic benefits of agents that alter cytokine pathways. (AM04)
- Nuclear receptors bridge the gap between signaling molecules and transcriptional responses; understanding their biology is critical for several classes of toxicants. (AM05)
- Understanding the capabilities and application of high throughput genomic and proteomic technologies enables an advanced understanding of mechanism of action. (AM06)
- Understanding underlying biology and function, as well as required study designs, is a must in characterizing and communicating the implications of developmental and reproductive toxicology findings. (AM07)
- Recognizing the species-specific nature of species-dependent differences in ocular anatomy and physiology is a requirement for accurate identification of toxicant-induced injury. (PM08)
- Gene-environment interactions can alter the pathogenesis of inflammatory and immune-mediated diseases modulated by cytokines. (PM09)
- The impact of mitochondrial dysfunction on diseases and toxicity requires knowledge of the fundamental biology and biochemistry of the cellular powerhouse. (PM10)
- Understanding the most current international guidelines for preclinical drug development keeps some toxicologists ahead of the game. (PM11)
- Knowledge of species- and age-specific changes in kidney structure and function is required to determine the human relevance of experimentally-observed lesions. (PM12)
- Recent advances in non-whole animal technologies are fostering a better understanding of drug and chemical-induced toxicities and their relationship to dose. (PM13)
The course levels are basic or advanced and are open to all meeting attendees with a separate registration fee. Additional information about these courses, including a detailed overview and list of speakers, can be found on the Continuing Education section of the SOT 2010 Annual Meeting Web site.
|
